CA49937-2 - 0x000000000000699D

Males & Females of Non-Childbearing Potential

Morning

* Stipend may pay up to reflected amount.
Start Date: 
February 1, 2026 - 1:30pm
End Date: 
April 13, 2026 - 9:00am

Study Details

Study Number: CA49937
Group Number: 2
Study Requirement: Healthy Normal Male and Female
Stipend: up to $7,000.00

Study Criteria

Age: 19 - 55
BMI: 0 - 0
Weight Restriction: minimum weight 0 lbs

Study Information

Indication: This investigational medication is being developed to treat inflammatory bowel disease.
Route of Administration: Injection IV infusion; Injection subcutaneous
Blood Draws: 16

Study Schedule

Schedule Type: Short stays with returns
Study Length: 5 Night Stay & 5 Returns

Screening Dates:

Event Day Event Date
Wednesday 1/21/2026
Tuesday 1/27/2026
Friday 1/30/2026

Doctor Exam Dates:

Event Day Event Date
Wednesday 1/21/2026
Tuesday 1/27/2026
Friday 1/30/2026

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Sunday 2/1/2026 1:30:00 PM Friday 2/6/2026 8:00:00 AM 1 Lincoln
Return Wednesday 2/11/2026 6:50:00 AM Wednesday 2/11/2026 8:00:00 AM 1 Lincoln
Return Monday 2/16/2026 6:50:00 AM Monday 2/16/2026 8:00:00 AM 1 Lincoln
Return Monday 3/2/2026 6:50:00 AM Monday 3/2/2026 8:00:00 AM 1 Lincoln
Return Monday 3/16/2026 7:50:00 AM Monday 3/16/2026 9:00:00 AM 1 Lincoln
Return Monday 4/13/2026 7:50:00 AM Monday 4/13/2026 9:00:00 AM 1 Lincoln